Association between lung function and exacerbation frequency in patients with COPD.

Area of Science:

• Pulmonary Medicine
• Respiratory Research
• Clinical Epidemiology

Background:

• Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease characterized by frequent exacerbations.
• The Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification system stratifies COPD severity based on airflow limitation.
• Understanding the relationship between GOLD stage and exacerbation frequency is crucial for patient management and resource allocation.

Purpose of the Study:

• To quantify the relationship between Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage and annual exacerbation frequency in patients with Chronic Obstructive Pulmonary Disease (COPD).
• To provide data for health economic and modeling purposes related to COPD exacerbations.

Main Methods:

• A systematic literature review of randomized controlled trials and cohort studies was conducted.
• Annual exacerbation frequencies (event-based, symptom-based, severe) were determined for COPD patients on usual care or placebo.
• Weighted log-linear regression analysis was used to associate mean FEV(1)% predicted with exacerbation frequencies and estimate rates per GOLD stage.

Main Results:

• Thirty-seven studies were included, reporting on exacerbation frequencies.
• Annual event-based exacerbation frequencies increased with GOLD stage, ranging from 0.82 in mild to 2.10 in very severe COPD.
• Annual frequencies for severe exacerbations (hospitalization) also increased with GOLD stage, from 0.11 to 0.28.

Conclusions:

• This study provides quantitative estimates of annual exacerbation frequencies stratified by GOLD stage for COPD.
• These estimates can inform health economic evaluations and disease modeling for COPD.
• The findings highlight a clear association between increasing COPD severity (GOLD stage) and higher exacerbation rates.